Novel benzazepines and related heterocyclic derivatives which are useful as orexin receptor antagonists
申请人:——
公开号:US20040058912A1
公开(公告)日:2004-03-25
The invention relates to novel benzazepines and related heterocyclic derivatives (I) and their use as active ingredients in the preparation of pharmaceutical compositions. The invention also concerns related aspects including processes for the preparation of the compounds, pharmaceutical compositions containing one or more of those compounds and especially their use as orexin receptor antagonists.
NOVEL BENZAZEPINES AND RELATED HETEROCYCLIC DERIVATIVES WHICH ARE USEFUL AS OREXIN RECEPTOR ANTAGONISTS
申请人:Actelion Pharmaceuticals Ltd.
公开号:EP1347967A1
公开(公告)日:2003-10-01
US7192950B2
申请人:——
公开号:US7192950B2
公开(公告)日:2007-03-20
[EN] NOVEL BENZAZEPINES AND RELATED HETEROCYCLIC DERIVATIVES WHICH ARE USEFUL AS OREXIN RECEPTOR ANTAGONISTS<br/>[FR] NOUVELLES BENZAZEPINES ET DERIVES HETEROCYCLIQUES ASSOCIES, UTILISES COMME ANTAGONISTES DU RECEPTEUR DE L'OREXINE
申请人:ACTELION PHARMACEUTICALS LTD
公开号:WO2002051838A1
公开(公告)日:2002-07-04
The invention relates to novel benzazepines and related heterocyclic derivatives (I) and their use as active ingredients in the preparation of pharmaceutical compositions. The invention also concerns related aspects including processes for the preparation of the compounds, pharmaceutical compositions containing one or more of those compounds and especially their use as orexin receptor antagonists.
[EN] NOVEL BENZAZEPINES AND RELATED HETEROCYCLIC DERIVATIVES<br/>[FR] NOUVELLES BENZAZEPINES ET DERIVES HETEROCYCLIQUES ASSOCIES
申请人:ACTELION PHARMACEUTICALS LTD
公开号:WO2002051232A2
公开(公告)日:2002-07-04
The invention relates to novel benzazepines and related heterocyclic derivatives and their use as active ingredients in the preparation of pharmaceutical compositions. The invention also concerns related aspects including processes for the preparation of the compounds, pharmaceutical compositions containing one or more of those compounds and especially their use as orexin receptor antagonists.